Skip to main content

View full-text article in PMC

. 2015 Sep 10;6(32):33972–33981. doi: 10.18632/oncotarget.5583

Table 3. Univariate and multivariate analyses for OS.

Variables	Univariate				Multivariate
	HR	95%CI		P-value	HR	95% CI		P-value
	HR	Lower	Upper	P-value	HR	Lower	Upper	P-value
Age (continue)	1.005	0.990	1.021	0.477	1.249	0.685	2.276	0.469
Tumor size(>20 vs. ≤20 mm)	2.648	1.679	4.174	<0.001	1.880	1.183	2.990	0.008
Grade(III vs. I-II)	1.242	0.916	1.683	0.163
LN status(pos vs. neg)	4.718	3.080	7.226	<0.001	2.222	1.9056	2.592	<0.001
ER (pos vs. neg)	0.871	0.755	1.005	0.059
PR(posvs. neg)	0.797	0.687	0.926	0.003	0.908	0.420	1.963	0.806
HER2 status (pos vs. neg)	1.118	0.881	1.419	0.360
ki67 (>14% vs. ≤14%)	0.831	0.487	1.417	0.497
PD-L1 (pos vs. neg)	2.262	1.598	3.203	<0.001	1.788	1.195	2.674	0.005
TNBC (yes vs. no)	1.454	1.003	2.108	0.048	1.398	0.606	3.225	0.432

Abbreviation: LN, lymph node; pos, positive, neg, negative; TNBC, triple-negative breast cancer.